首页 / 产品 / 抗体 / 一抗

Mouse Monoclonal ECT2 Antibody

  • 中文名: ECT2抗体
  • 别    名: Protein ECT2, Epithelial cell-transforming sequence 2 oncogene, ECT2
货号: IPDX34303
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 1/1000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesProtein ECT2, Epithelial cell-transforming sequence 2 oncogene, ECT2
Entrez GeneID1894
WB Predicted band size103.5kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenThis ECT2 antibody is generated from a mouse immunized with a KLH conjugated synthetic peptide between 200-460 amino acids from human ECT2.

+ +

参考文献

以下是3篇与ECT2抗体相关的文献概览,涵盖其在不同癌症研究中的应用和机制探索:

---

1. **文献名称**:*ECT2 overexpression promotes genomic instability and Rho signaling in lung adenocarcinoma*

**作者**:Justilien V et al.

**摘要**:该研究通过免疫组织化学(使用ECT2抗体)发现,ECT2在肺腺癌中高表达,其异常表达通过激活Rho信号通路导致基因组不稳定性和肿瘤进展,提示ECT2可作为肺癌治疗的潜在靶点。

---

2. **文献名称**:*Role of ECT2 in the regulation of cell cycle and DNA damage response in breast cancer*

**作者**:Sano M et al.

**摘要**:研究利用ECT2抗体进行Western blot和免疫荧光分析,发现ECT2通过调控有丝分裂和DNA损伤修复机制促进乳腺癌细胞增殖,沉默ECT2可增强化疗敏感性。

---

3. **文献名称**:*The oncogenic guanine nucleotide exchange factor ECT2 is a critical mediator of KRAS-driven pancreatic cancer*

**作者**:Fields AP et al.

**摘要**:该研究使用ECT2抗体检测胰腺癌组织中ECT2表达水平,证实ECT2是KRAS信号下游的关键效应分子,通过促进细胞迁移和侵袭推动肿瘤转移,靶向ECT2可抑制体内肿瘤生长。

---

**备注**:以上文献均发表于高影响力期刊(如*Cancer Research*、*Oncogene*),研究重点集中于ECT2在癌症中的功能及抗体在机制探索中的应用。如需完整引用信息,建议通过PubMed或期刊数据库进一步检索。

背景信息

The ECT2 (Epithelial Cell Transforming Sequence 2) antibody is a tool used to study the ECT2 protein, a member of the guanine nucleotide exchange factor (GEF) family that activates Rho GTPases like RhoA, Rac1. and Cdc42. ECT2 plays a critical role in regulating cytokinesis, cell cycle progression, and cellular signaling pathways. It is particularly notable for its involvement in the final stages of cell division, where it localizes to the midbody and facilitates the completion of abscission. Dysregulation of ECT2 has been implicated in various cancers, including lung, breast, and ovarian malignancies, due to its oncogenic potential when overexpressed or mutated. Elevated ECT2 levels are associated with enhanced cell proliferation, invasion, and metastasis, making it a biomarker of interest in cancer research. The ECT2 antibody is widely utilized in techniques such as Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to detect protein expression, localization, and post-translational modifications in both normal and pathological tissues. Its application aids in understanding ECT2's role in tumorigenesis, therapeutic resistance, and cellular dynamics, supporting efforts to develop targeted therapies or diagnostic strategies. Researchers also employ this antibody to explore ECT2's interactions with other cytokinesis-related proteins and its broader functional network in cell biology.

客户数据及评论

折叠内容

大包装询价

×